Video Module

New Insights Into the Use of Pls Across the Treatment Spectrum

Source: New Insights Into the Use of PIs Across the Treatment Spectrum*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

New Insights Into the Use of Pls Across the Treatment Spectrum

Faculty:

Edwin DeJesus, MD, FACP, AAHIVS
W. David Hardy, MD
Charles B. Hicks, MD

CME CREDIT INFORMATION

Release Date: 07/11/08

Expiration Date: 07/10/09

Physicians: maximum of 1.75 AMA PRA Category 1 Credits™

Registered Nurses: 1.8 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the findings from recent studies of PI-containing regimens in HIV-infected patients across the treatment spectrum
Recount considerations that influence the choice between available PIs in treatment-naive patients, including efficacy, tolerability, and the consequences of virologic failure
Discuss the evidence-based choice of a new PI in moderately treatment–experienced patients
Describe the role of PIs in combination with other active agents, including novel antiretrovirals, when constructing new regimens for extensively pretreated patients

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.